Page 3 - க்ளேண்மர்க் மருந்துகள் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்ளேண்மர்க் மருந்துகள் இந்தியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்ளேண்மர்க் மருந்துகள் இந்தியா Today - Breaking & Trending Today

Glenmark launches nasal spray for allergic rhinitis in India

Chennai: Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment ....

Tamil Nadu , Glenmark Pharmaceuticals Limited On , Glenmark Pharmaceuticals Limited , Nasal Spray , தமிழ் நாடு , க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை ,

Glenmark arm files IPO papers with SEBI - The Hindu BusinessLine

Glenmark arm files IPO papers with SEBI
April 17, 2021
Plans to sell over 73 lakh shares via Offer For Sale
Glenmark Life Sciences Limited, a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer.
The company plans to raise ₹1,160 crore with an Offer For Sale of up to 7,305,245 equity shares of ₹2 each of Glenmark Life Sciences Limited. The board of directors of Glenmark Pharmaceuticals Limitedon Friday approved the OFS.
Glenmark Pharma holds 100 per cent stake in Glenmark Life Sciences, which is primarily into manufacturing and marketing of Active Pharmaceutical Ingredients (APIs). It has a product portfolio of more than 130 APIs and a catalogue of over 270 inventions. The firm, which supplies APIs to more than 700 customers across 65 countries, also develops 10-12 new products every year. Glenmark Life Sciences has manufacturing op ....

Glenmark Pharma , Glenmark Life Sciences , Glenmark Pharmaceuticals Limitedon , Exchange Board Of India , Glenmark Pharmaceuticals , Glenmark Life Sciences Limited , Glenmark Pharmaceuticals Limited , Exchange Board , Offer For Sale , Glenmark Pharmaceuticals Limitedon Friday , Active Pharmaceutical Ingredients , Life Sciences , க்ளேண்மர்க் பார்மா , க்ளேண்மர்க் வாழ்க்கை அறிவியல் , பரிமாற்றம் பலகை ஆஃப் இந்தியா , க்ளேண்மர்க் மருந்துகள் , க்ளேண்மர்க் வாழ்க்கை அறிவியல் வரையறுக்கப்பட்டவை , க்ளேண்மர்க் மருந்துகள் வரையறுக்கப்பட்டவை , பரிமாற்றம் பலகை , சலுகை க்கு விற்பனை , செயலில் மருந்து பொருட்கள் , வாழ்க்கை அறிவியல் ,

pharma stocks: Pharma stocks momentum is not going to abate anytime soon

Explore Now
Nifty and Bank Nifty have failed to break past that gap down, which was created post the Monday selling and that has really hurt the sentiments for the indices, says the independent market expert Kunal Bothra. Excerpts from an interview:
We had a scary Monday and since then we saw a steady rebound coming in. Is the rebound enough for us to not test Monday’s lows of 14,320?
We saw more of a repel trade or a repair mode in the second half of the week. The Monday selloff put in quite a dent into the indices. If you look at the momentum, there is hardly any major build up of open interest, except for Thursday when the markets opened after a one-day holiday. You saw a jump in the open interest on the Bank Nifty but other than that, there is hardly any major position sizing that has built up into the indices, which means that the market participants are expecting that the index could remain more or less in a range. ....

Kunal Bothra , Bank Nifty , Divi Lab , Pharma Stocks , Sun Pharma , Aurobindo Pharma , Market Momentum , குணால் போத்ரா , வங்கி நிஃப்டி , டிவி ஆய்வகம் , பார்மா ஸ்டாக்ஸ் , சூரியன் பார்மா , அரவிந்தோ பார்மா , சந்தை வேகத்தை ,

Welcome To IANS Live - BUSINESS - Glenmark Pharma to use IFC's $40 mn loan for debt refinance and capex

Photo Credit: IANS
IANSLive
Chennai, April 6 (IANS) Pharma major Glenmark Pharmaceuticals Ltd will be utilising the $40 million loan from International Finance Corporation (IFC) to refinance existing debt and for capital expenditure.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 06-April-2021 ....

Tamil Nadu , Glenmark Pharma , International Finance Corporation , News Service , India Private , Glenmark Pharmaceuticals Ltd , All Rights , Project According , Funding The , தமிழ் நாடு , க்ளேண்மர்க் பார்மா , சர்வதேச நிதி நிறுவனம் , செய்தி சேவை , இந்தியா ப்ரைவேட் , க்ளேண்மர்க் மருந்துகள் லிமிடெட் , அனைத்தும் உரிமைகள் , ப்ராஜெக்ட் இசைய , நிதி தி ,

market analysis: F&O: Nifty forms higher highs, crosses recent swing high in hope for the bulls

Explore Now
Nifty opened positive on Thursday and after a slight dip in the initial hours, took support near the 14,700 mark. The index witnessed a strong move in the second half of the session and headed towards the 14,883 level. It has been forming higher lows since last four sessions and managed to cross the recent swing high, which bodes well for the bulls.
The index settled the day with a gain of around 170 points and formed a bullish candle with a long lower shadow, which signalled buying on declines. Now, it has to hold above 14,800 level to witness a bounce towards 15,000 and 15,100 levels, while on the downside support exists at 14,700 and 14,600 levels. ....

Sun Pharma , Bank Nifty , Put Open Interest , Inside Bar , Adani Enterprises , Shriram Transport , Tata Chemicals , Ramco Cement , Ultratech Cement , Tata Consumers , Market Analysis , Jindal Steel , Post Market , Tata Steel , சூரியன் பார்மா , வங்கி நிஃப்டி , போடு திறந்த ஆர்வம் , உள்ளே மதுக்கூடம் , அதானி நிறுவனங்கள் , ஸ்ரீராம் போக்குவரத்து , டாடா இரசாயனங்கள் , ராம்கோ சிமென்ட் , அல்ட்ராடெக் சிமென்ட் , டாடா நுகர்வோர் , சந்தை பகுப்பாய்வு , ஜிண்டால் எஃகு ,